FDA
-
-
-
-
-
-
-
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
-
-
-
-
-
-
-
Quest Diagnostics wins FDA breakthrough status for cancer test
-
-
-
-
-
-
-
Quest Diagnostics (DGX) Appoints Adrienne Brott as Chief Quality and Regulatory Affairs Officer
-
-
-
-
-
-
-
Becton Dickinson (BDX) and Quest Diagnostics (DGX) Collaborate to Develop Companion Diagnostics for Cancer, Other Diseases
-
-
-
-
-
-
-
Diadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer's Disease Prognostic Technology
-
-
-
-
-
-
-
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
-
-
-
-
-
-
-
Physicians Foresee an Alzheimer's Disease Treatment Revolution Supported by Advanced Testing Tools, New Quest Diagnostics Report Finds
-
325,489 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

